Moderna
MRNA
#1168
Rank
$16.05 B
Marketcap
$41.71
Share price
-0.29%
Change (1 day)
-51.51%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Cash on Hand

Cash on Hand as of September 2024 : $6.86 Billion USD

According to Moderna 's latest financial reports the company has $6.86 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Moderna - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$8.60 B-13.11%
2022-12-31$9.90 B-7.69%
2021-12-31$10.72 B132.79%
2020-12-31$4.60 B317.77%
2019-12-31$1.10 B-27.5%
2018-12-31$1.52 B101.24%
2017-12-31$0.75 B-28.55%
2016-12-31$1.05 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$87.3 M-98.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.59 B 112.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.02 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.78 B-59.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.02 B 104.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$0.68 B-90.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.29 B 195.57%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA